Perseus Proteomics Reports Non-operating Income, Expenses for Q1 FY2025

MT Newswires34minutes ago

Dentsu Group revised downwards to 107.1 billion yen in operating profit, from 135.4 billion yen on 24 December.

Dentsu Group (4324) announced a revision of its financial estimates for the fiscal year ending in December 2024, lowering its operating profit from 135.4 billion yen to 107.1 billion yen due to anticipated revenue deficits in Asia-Pacific regions such as China and Australia, resulting in impairment losses. Additionally, expenses related to the sale of its business in Russia, against the background of the Ukrainian invasion, have exceeded expectations. Plus evaluation: Skylark (3197), Medpeer (6095), Yonshan Holdings (3962).

Fisco Japan16:56 ET

Perseus Proteomics Reports Mixed Financial Activities

TipRanksAug 14 02:38 ET

Perseus Proteomics: March 2025 First Quarter Fiscal Results Announcement [Japanese Standards] (Non-consolidated)

JPXAug 14 02:05 ET · Announcements

Perseus Proteomics 1Q Parent Loss Y219.00M Vs Loss Y422.00M

Dow JonesAug 14 02:05 ET

Skylark, Dentsu G, Ebara, Asahi Intec (14th)

*The above calendar is subject to change due to company circumstances. --------------------------------------- August 14th (Wed) <1380> Akikawa Bokuen <1443> GikenHD <147A> Solacom <1491> Chugai Mining <149A> Shinka <157A> Green Monster <160A> Az Partners <1711> SDSHD 1

Fisco JapanAug 13 17:30 ET